Pipeline

Our platform technology consists of a pipeline of immunoactivator peptides that stimulate an immune response, while eliminating accompanying inflammatory activity. They can be used as activators, molecular adjuvants or conjugated to antigens to generate a wide range of immune responses to pathogens.

Focus

Prommune Inc. currently has three candidate products at the clinical stage with respect to influenza A infections in pigs. The company is also working on a vaccine for a human parasitic infection which is at an early stage of development.

Research

Our technology is backed by more than 20 peer-reviewed publications covering its development and therapeutic use in humans and animals.

Focus

Prommune Inc. currently has three candidate products at the clinical stage with respect to influenza A infections in pigs. The company is also working on a vaccine for a human parasitic infection which is at an early stage of development.

Research

Our technology is backed by more than 20 peer-reviewed publications covering its development and therapeutic use in humans and animals.

info@prommuneinc.net

9393 W. 110th St
Suite 500, PMB#5040
Overland Park, KS 66210

+1 (877) 426-9009